|1.||Szponar, Jarosław: 1 article (01/2012)|
|2.||Danielewicz, Piotr: 1 article (01/2012)|
|3.||Majewska, Magdalena: 1 article (01/2012)|
|4.||Drelich, Grzegorz: 1 article (01/2012)|
|5.||Kołodziej, Małgorzata: 1 article (01/2012)|
|6.||Kostek, Halina: 1 article (01/2012)|
|7.||Wree, Andreas: 1 article (10/2011)|
|8.||Hofrichter, Jacqueline: 1 article (10/2011)|
|9.||Alfen, Franziska: 1 article (10/2011)|
|10.||Lange, Cathleen: 1 article (10/2011)|
|1.||Breast Neoplasms (Breast Cancer)
01/01/1991 - "Forty-six women with breast cancer treated with adjuvant FAC (fluorouracil, doxorubicin and cyclophosphamide) entered a multicenter, randomized, double-blind, cross-over trial in which thiethylperazine (T) (6.5 mg p.o every 8 h x 3 days) plus methylprednisolone (MP) (250 mg i.v. x 2 doses) was compared with thiethylperazine plus placebo. "
01/01/1991 - "The antiemetic efficacy of thiethylperazine and methylprednisolone versus thiethylperazine and placebo in breast cancer patients treated with adjuvant chemotherapy (fluorouracil, doxorubicin and cyclophosphamide). "
01/01/1992 - "The maintenance of the antiemetic efficacy of a combined protocol (intravenous methylprednisolone, oral thiethylperazine and oral amitriptyline) during six consecutive courses of adjuvant FAC chemotherapy (5-fluorouracil, doxorubicin, cyclophosphamide) was analysed in 107 female breast cancer patients who completed the six planned courses of treatment. "
01/01/2009 - "She was given thiethylperazine and vomiting resolved within an hour. "
12/01/2000 - "Emesis was mild and easily manageable with thiethylperazine given orally. "
09/01/1997 - "Emesis was mild and easily manageable with thiethylperazine. "
09/01/1993 - "Torecan did not prevent patients from vomiting. "
01/01/1990 - "The author summarizes the theoretical aspects of vomiting and alleviation of the same by surveying the respective scientific communications with special regard to thiethylperazine. "
|3.||Migraine Disorders (Migraine)
02/15/1964 - "NAUSEA AND VOMITING IN PREGNANCY: A TRIAL OF THIETHYLPERAZINE."
10/01/2011 - "In contrast, activation of ABCC1 using thiethylperazine (a drug approved by the FDA to relieve nausea and vomiting) markedly reduced Aβ load in a mouse model of AD expressing ABCC1 but not in such mice lacking ABCC1. "
04/01/1968 - "Effect of thiethylperazine as prophylaxis for nausea and vomiting in surgery."
01/01/1968 - "[Prevention of nausea and vomiting and their therapy with Torecan after ophthalmic surgery]."
12/01/1964 - "[ANTIEMETIC EFFECT OF THIETHYLPERAZINE FOR NAUSEA AND VOMITING ASSOCIATED WITH PNEUMOENCEPHALOGRAPHY]."
|5.||Vertigo (Positional Vertigo)
01/01/1966 - "A nystagmographic study of thiethylperazine in normal subjects and in patients with vertigo."
09/01/1965 - "THE CONTROL OF VERTIGO BY THIETHYLPERAZINE."
02/08/1964 - "[TREATMENT OF OTOGENIC VERTIGO WITH TORECAN]."
12/01/1963 - "[THE TREATMENT OF VERTIGO WITH THIETHYLPERAZINE. "
11/01/1962 - "[A new drug with action against vertigo: Torecan]."
|9.||Aspirin (Acetylsalicylic Acid)
|1.||Drug Therapy (Chemotherapy)
|3.||Oral Surgery (Maxillofacial Surgery)